
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES143
All reported CV outcomes were for beta-blockers vs CCBs. For the study considering COER verapamil and atenolol or hydrochlorothiazide there was NS difference between the groups for both the composite of acute MI, stroke or CV related death and also for the incidence of any component of the composite in the diabetic subgroup.261 Level 1+

[@Zanchetti_2006]

